Bloomberg
Moderna CEO Sees Cancer Vaccines Working Beyond Melanoma
Monday, October 26, 2026
Moderna CEO Stephane Bancel stated that the personalized mRNA cancer vaccine being developed with Merck could be effective across multiple tumor types. Bancel told Bloomberg that recent data regarding the cancer vaccine candidate did not originate from Moderna or Merck. The companies are continuing development of the vaccine candidate.
Original reporting:
